ARTICLE | Company News
Basilea infectious, dermatology news
October 10, 2011 7:00 AM UTC
HBM BioVentures said it is seeking to add four independent directors to Basilea's five-member board. HBM, which is Basilea's largest shareholder with an 18% stake, proposed the nominees "to support the evaluation and implementation of strategic decisions and to unlock Basilea's untapped potential," according to a letter to the company. ...